None
Conditions
Interventions
None listed
Sponsors
FANCL Corporation
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Japanese men and women between 40 and under 80 years of age at the time of consent 2. Subjects who experience a decline in walking function and muscle strength
Exclusion criteria
Exclusion criteria: 1. Subjects who are undergoing treatment for diseases related to the locomotor system, or subjects who have sequelae due to a history of such diseases 2. Subjects who have undergone joint replacement surgery or intra-articular injections of hyaluronic acid, steroids within 3 months of the date consent was obtained 3. Subjects who had a bone fracture within 1 year prior to obtaining consent to participate in this study 4. Subjects with bruises or sprains within 3 months prior to obtaining consent to participate in this study 5. Subjects who have been diagnosed with a cancer, subjects who are under treatment for or have a history of diseases such as brain, heart, renal, or psychiatric diseases, diabetes, thyroid dysfunction, or diseases that affect the secretion of adrenal cortical hormones, or subjects who have a history of serious diseases such as liver disease 6. Patients undergoing treatment for hypertension, unless the investigational doctor determines that there are no safety issues 7. who have been diagnosed with or are under treatment for cognitive dysfunction 8. Subjects who routinely use prescription drugs or over-the-counter drugs for more than 3 days per week. 9. Subjects who are engaged in strenuous physical activities that put stress on joints and muscles. 10. Subjects who are using a cane or supporter. 11. Subjects who regularly perform activities that may affect joints and muscles, such as massage, spa, bodywork, etc. 12. Subjects who have a cardiac pacemaker or other precision device implanted in their body. 13. Subjects who are heavy drinkers of alcohol 14. Subjects who have participated in other clinical studies within one month prior to obtaining consent to participate in this study, or who will participate in other clinical studies after obtaining consent to participate in this study 15. Subjects who intend to become pregnant or lactating 16. Subjects judged as unsuitable for the study by the investigational doctor for other reasons
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Body composition, CT of femur region, physical function tests, quality of life survey, dietary survey | — |
Countries
Japan
Contacts
Public ContactNoriko Ueda
EP Mediate Co., Ltd. Foods Department, Trial Planning Section 2
Outcome results
None listed